Willow Biosciences Inc.
CANSF
$0.02
-$0.0035-14.89%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.80% | 53.01% | 49.94% | 49.53% | 37.08% |
| Total Depreciation and Amortization | -20.34% | -6.05% | -27.45% | -10.38% | -22.69% |
| Total Amortization of Deferred Charges | -34.85% | -34.85% | -80.92% | -80.92% | -80.92% |
| Total Other Non-Cash Items | 683.54% | -23.20% | -18.77% | -107.34% | -195.32% |
| Change in Net Operating Assets | 5,095.24% | 439.46% | 220.96% | 228.24% | 104.17% |
| Cash from Operations | 77.87% | 66.42% | 67.86% | 60.26% | 40.02% |
| Capital Expenditure | 75.46% | 96.71% | 79.50% | 84.38% | 92.12% |
| Sale of Property, Plant, and Equipment | -100.00% | 1,862.75% | 78.61% | 14.47% | 14.47% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -158.75% | -100.94% | -118.42% | -88.68% | -45.14% |
| Cash from Investing | -145.82% | -97.76% | 93.70% | -25.20% | 116.08% |
| Total Debt Issued | -133.75% | -133.75% | 610.63% | -- | -- |
| Total Debt Repaid | 10.52% | 15.02% | 22.46% | -29.88% | -44.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 750.22% | 4,657.14% | 159.38% | 560.32% | 11,450.00% |
| Cash from Financing | 5,525.00% | 403.87% | 277.03% | 174.27% | 98.16% |
| Foreign Exchange rate Adjustments | 148.30% | 150.00% | -108.13% | 29.03% | -125.97% |
| Miscellaneous Cash Flow Adjustments | -3,121.88% | 143.75% | 199.20% | -- | -- |
| Net Change in Cash | 84.03% | 64.73% | 80.96% | 63.21% | 45.23% |